WE are an association of 26 leading pharmaceutical companies united under the common goal of promoting faster and broader access to innovative treatments in Greece.
WE are an interlocutor joining forces with the Greek authorities to contribute to establishing a high-quality healthcare system.
WE are an enabler aspiring to contribute to Greece’s prosperity, growth and competitiveness.
Fewer than 2 out of 10 treatments are covered by the state, severely limiting patients’ access to innovative and critical therapies. Following the meeting between the Minister of Health, Mr.…
PhARMA Innovation Forum (PIF) and its 26 biopharmaceutical member companies express their deep concern over the impasse regarding patient access to innovative therapies. According to official data from the National…
Το ζήτημα της δημόσιας χρηματοδότησης της φαρμακευτικής δαπάνης αναδεικνύει ως πρωτεύουσας σημασίας και ύψιστης προτεραιότητας για την άνθιση της καινοτομίας στη φαρμακοβιομηχανία, η κυρία Λαμπρίνα Μπαρμπετάκη, πρόεδρος του PhARMA Innovation Forum…
